RecruitingNot ApplicableNCT05914766

An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer

PATHWAYS: An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer


Sponsor

Massachusetts General Hospital

Enrollment

80 participants

Start Date

Sep 21, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to evaluate the feasibility and acceptability of conducting a randomized trial of a brief psychoeducational intervention versus enhanced usual care for patients with locally advanced rectal cancer who are initiating neoadjuvant multimodality treatment.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age≥18 years
  • Within 8 weeks after documented decision to pursue multi-modality therapy for newly diagnosed LARC (i.e., stage II or III disease)
  • Able to complete study procedures English or with the assistance of an interpreter

Exclusion Criteria2

  • Comorbid health condition that would interfere with study participation, as identified by cancer care team
  • Has undergone treatment for a prior colorectal cancer

Interventions

BEHAVIORALPATHWAYS

The PATHWAYS intervention is a psychoeducational intervention comprised of four behavioral coaching sessions and a patient education guidebook.

OTHEREnhanced usual care

The enhanced usual care condition consists of an information resource guide.


Locations(2)

Massachusetts General Hospital

Boston, Massachusetts, United States

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05914766


Related Trials